Puma Goes Back to the Future With Computerized Running Shoes
Bayer's Health Unit Pinches Pennies With Monsanto Draining Cash
Bayer AG plans to cut 12,000 jobs and exit its animal health business in an effort to mollify Wall Street.
Bayer Earnings Beat Estimates Amid Monsanto Growing Pains
Lundbeck's Failed Drug Wipes $4 Billion Off Its Market Value
Breaking Into Breast Cancer, Immune Therapy Shows Wider Promise
Roche Immune Drug Helps Patients With Aggressive Breast Cancers
Astra's Lynparza Boosts Survival in Ovarian Cancer Patients
Roche's Old Guard of Big Drugs Holds Up in Face of New Foes
Why Merkel Is Watching Wealthy Bavaria This Weekend
Sneaking Into Patients’ Pockets, One Medical App at a Time
Roche Wins U.S. Nod to Sell Hemlibra to Most Hemophilia Patients
A Power Grid and Its Customers Could Get Stuck Paying for a Failed Wall Street Bet
Roche CEO Refuses to Cede Cancer's Hottest New Field to Merck
Roche CEO Slams U.K. Health System for Slowing Innovation
That’s no surprise to residents of Bavaria, where beer is king.
Bayer $63 billion Monsanto purchase has suffered regulatory delays, mounting legal claims and yields short of forecasts.
Trump Promised to Bring Back Coal. It’s Declining Again
New York's Muggy Night Sent Wholesale Power to Four-Year High
Summer Heat Has Canadians Using Power Like It's Hockey Season
The big bright spot for U.S. coal miners is located halfway around the world.